NGT’s Crystallization and Solid-State Subject Matter Expert, Dr. Robert Dennehy, is one of three recent appointments to the Strategic Advisory Board at CatSci.
Click here to read the press release.
“Dr Robert Dennehy is a consultant in pharmaceutical solid state and crystallisation, with 27 years of industry experience gained at GSK. This experience – the latter of which was at a Senior Director level – covers all stages of development, from pre-phase I solid state selection through to QbD regulatory filing. In addition, Robert has led the technical development of major assets to market and will support CatSci through his expertise in pre-formulation and pharmaceutical development.”
Dr. Dennehy said: “I am really excited at the prospect of growing the materials sciences capability at CatSci. I believe that good science and sound methodology are key in making the best decisions in developing a drug. The culture at CatSci is dynamic and innovative; together with my industry experience, our partnership will be a winning combination!”
For more information on Robert’s expertise, or to get in touch regarding your drug development project, contact us here.